| Primary information |
|---|
| ID | 20099 |
| Pubchem ID | 3032303 |
| Name | Oxymetholone |
| Description | A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002); this compound may reasonably be anticipated to be a carcinogen. (From Merck Index; 11th ed) |
| Synonym | Oxymetholone Oximetholonum Anasterone Oximetalonu Oximetolona Oxymethalone Plenastril Protanabol Synasteron |
| Molecular Weight | 332.48 |
| Formula | C21H32O3 |
| IUPAC | (2E;5S;8R;9S;10S;13S;14S;17S)-17-hydroxy-2-(hydroxymethylidene)-10;13;17-trimethyl-1;4;5;6;7;8;9;11;12;14;15;16-dodecahydrocyclopenta[a]phenanthren-3-one |
| SMILE | CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C |
| PDB ID | NA |
| KEGG | C07393; D00490 |
| HMDB ID | NA |
| Melting Point (Degree C) | 179 |
| Water Solubility | NA |
| Drugbank ID | NA |
| Receptor | Q9TT90; Q8MIK0; O97776; P10275; O97952; Q6QT55; P19091; O97775; O97960; Q9GKL7; P49699; Q7T1K4; P15207; O18925; O18928; O55065; O55066; O93244; O93245 |
| Reference | Pubchem
|